Advertisement

Topics

Latest "Center for Infectious Disease Research" News Stories

08:47 EST 14th November 2018 | BioPortfolio

Here are the most relevant search results for "Center for Infectious Disease Research" found in our extensive news archives from over 250 global news sources.

More Information about Center for Infectious Disease Research on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Center for Infectious Disease Research for you to read. Along with our medical data and news we also list Center for Infectious Disease Research Clinical Trials, which are updated daily. BioPortfolio also has a large database of Center for Infectious Disease Research Companies for you to search.

Showing "Center Infectious Disease Research" News Articles 1–25 of 45,000+

Wednesday 14th November 2018

Nymox Pharmaceutical Corp NYMX Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryNymox Pharmaceutical Corp Nymox is a biopharmaceutical company that undertakes the research and development of therapeutics and diagnostics devices to target the unmet needs of the aging population. The company markets diagnostic products for measuring tobacco product exposure and for the diagnosis of Alzheimer's disease. Its diagnostic product portfolio includes NicAlert test to determine ...


ADC Therapeutics Announces Presentations at 60th American Society of Hematology (ASH) Annual Meeting

EQS Group-News: ADC Therapeutics SA / Key word(s): Conference 14.11.2018 / 13:30 ADC Therapeutics Announces Presentations at 60th American Society of Hematology (ASH) Annual Meeting   New clinical data highlight potential of novel pyrrolobenzodiazepine-based antibody drug conjugates for the treatment of relapsed or refractory lymphomas Lausanne, Switzerland, November 14, 2018 - ...

Bio-Rad and the University of Chicago Win Patent Infringement Case Against 10X Genomics Related to Droplet Microfluidics Technologies

A Federal District Court jury yesterday found that 10X Genomics willfully infringed three United States patents owned by the University of Chicago and exclusively licensed to Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products (NYSE: BIO and BIOb). In awarding Bio-Rad $23.9 million in damages, the jury una...


Blue Earth Diagnostics Announces 18F-Fluciclovine Research Presentation at Upcoming Society for Neuro-Oncology (SNO) Annual Scientific Meeting

Blue Earth Diagnostics, a molecular imaging diagnostics company, today announced that a presentation related to the clinical use of 18F-fluciclovine in adults with glioma will be occurring at the upcoming Society for Neuro-Oncology (SNO) Annual Scientific Meeting, being held November 15 - 18, 2018 in New Orleans, La. Blue Earth Diagnostics is investigating the ...

Myomo Announces First Adolescent Patients to be Fitted with MyoPro

Robotic lightweight wearable device empowers young adults with arm paralysis to live independently, while also reducing healthcare costs Myomo, Inc., a wearable medical robotics company, has achieved recent momentum fitting and delivering MyoPro to adolescent users. Approved to assist young adults suffering from any disease or injury leaving them with ...

HHS is bringing in scientists to defend their use of fetal tissue in research, the next step in a department-wide audit that includes FDA and NIH. https://buff.ly/2TbIZUw 

HHS is bringing in scientists to defend their use of fetal tissue in research, the next step in a department-wide audit that includes FDA and NIH. https://buff.ly/2TbIZUw 

iSchemaView RAPID™ Integrates with Join, Allm’s Medical Communications Platform

RAPID’s Advanced Imaging Results, the Standard for Over 700 Stroke Centers, Now Also Available via Join’s Medical Communications App. iSchemaView, the worldwide leader in advanced imaging for stroke, today announced that the RAPID platform is now compatible with Join, a medical communication app developed by Allm, a multinational developer of mobile ...

Seattle Genetics Initiates Phase 1 Clinical Trial of SEA-BCMA for Patients with Relapsed or Refractory Multiple Myeloma

-SEA-BCMA is a Novel Empowered Antibody Targeting BCMA for Multiple Myeloma- -Adds to Seattle Genetics’ Robust Clinical-Stage Development Pipeline across Multiple Hematologic and Solid Tumors- Seattle Genetics, Inc. (Nasdaq:SGEN) announced today dosing of the first

Bayer’s Regorafenib is the First Drug to Enter GBM AGILE

The Global Coalition for Adaptive Research (GCAR) and Bayer announced today that Bayer’s regorafenib will be the first drug to enter “GBM AGILE” (Glioblastoma Adaptive Global Innovative Learning Environment). GBM AGILE is a revolutionary patient-centered adaptive platform trial that will evaluate multiple therapies for patients with newly diagnosed a...

ivWatch Extends Patient Monitor to International Markets

ivWatch, the only provider of continuous patient monitoring devices for the early detection of intravenous (IV) infiltrations and extravasations, announces a new international partner to manage distribution to support market expansion outside of the United States. Following the

Cigna Collaborates with Annum Health to Introduce a Digital Health Solution to Help People Reduce Alcohol Consumption

Innovative program allows people to privately connect with health professionals and peers, track their alcohol consumption, and take steps to improve well-being Cigna is the first health service company to collaborate with Annum Health Global health service company Cigna is collaborating with Annum Health to ...

Stemtech Launches OraStem™ Toothpaste

All-Natural Product, So Innovative, Patents Are Pending Stemtech Corporation recently expanded its product line with its entrée into the oral care category, by introducing OraStem – the world’s most advanced all-natural tooth-whitening toothpaste www.stemtech.com/us/en/Products/OraStem. Ray Carter, Stemtech CEO, commented: “this is another maj...

Bicycle Therapeutics Named Best New Drug Developer at 2018 World ADC Awards

Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (Bicycles™) product platform, today announced that it has been recognized at the 2018 World ADC Awards, held during the World ADC Conference in San Diego, Calif., as Best New Drug Developer. The award honors a company in...

ImmunoMolecular Therapeutics Awarded SBIR Grant and Receives Rare Pediatric Disease Designation from FDA for IMT-002

-- SBIR grant awarded to develop D-MDOPA for the preservation of residual beta cell function in type 1 diabetes -- -- Rare Pediatric Disease designation granted to IMT-002 for type 1 diabetes-- ImmunoMolecular

US FDA Awards Certara’s Simcyp Division Two New Dermal Virtual Bioequivalence Grants

New grants support FDA’s GDUFA priorities of expanding bioequivalence methods for topical dermatological products and improving PBPK models of drug absorption via complex delivery routes Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access, today announced that it has been awarded ...

ICON Plc ICLR Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryICON plc ICON is a contract research organization CRO that provides outsourced development services to the biotechnology, pharmaceutical and medical device industries worldwide. It provides a range of specialized services that span the entire lifecycle of product development. The company's service portfolio includes adaptive trials, biosimilars, clinical research services, commercialization...

UDG Healthcare Plc UDG Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryUDG Healthcare plc UDG formerly, United Drug plc is a provider of outsourced commercial solutions to healthcare companies. It offers supply chain, packaging, sales and marketing, medical and regulatory services to healthcare manufacturers and pharmaceutical retailers. Its major activities include contract sales outsourcing and related marketing and regulatory services; healthcare logistics ...

Amphastar Pharmaceuticals Inc AMPH Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryAmphastar Pharmaceuticals Inc Amphastar is a specialty pharmaceutical company that develops, manufactures and markets generic and proprietary injectable, intranasal and inhalation products. It also sells insulin active pharmaceutical ingredient insulin API products. The company's products includes enoxaparin sodium injection; cosyntropin for injection; naloxone hydrochloride HCl injection a...

Verona Pharma Plc VRP Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryVerona Pharma Plc Verona Pharma is a clinicalstage biotechnology company, which focuses on the research, discovery and development of firstinclass therapeutic drugs for the treatment of chronic respiratory and inflammatory diseases. The company's lead candidate, RPL554 is a bronchodilator/antiinflammatory drug which is being developed for a wide range of indications including chronic obstru...

Siemens AG SIE Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummarySiemens AG Siemens is a technology company that offers products and solutions for electrification, automation and digitization. The company offers products, services and solutions for power generation, transmission and distribution; oil and gas production and transportation; medical imaging and laboratory diagnostics; audiology solutions; industrial technologies and automation systems; infr...

Elite Pharmaceuticals Inc ELTP Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryElite Pharmaceuticals Inc Elite is a specialty pharmaceutical company focuses on the development of oral sustained and controlled release drug products. The company manufactures and develops generic drugs with Abbreviated New Drug Applications ANDA and branded drugs with New Drug Application NDA for the treatment of pain, obesity, hypertension, depression, infection and allergy, among other...

Alnylam Pharmaceuticals Inc ALNY Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryAlnylam Pharmaceuticals Inc Alnylam is a biopharmaceutical company which discovers, develops and commercializes therapeutics based on Ribo Nucleic Acid interference RNAi. The company offers a broad pipeline of investigational RNAi therapeutics in the areas of genetic medicines, hepatic infectious diseases, cardiometabolic diseases, and central nervous system CNS diseases. Its late stage pro...

BioCryst Pharmaceuticals Inc BCRX Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryBioCryst Pharmaceuticals Inc BioCryst designs, optimizes and develops small molecule drugs that block key enzymes in the pathogenesis of diseases. The company focuses on the treatment of rare diseases and develops drugs for infectious diseases and hereditary Angioedemaon. Biocryst integrates disciplines of biology, crystallography, medicinal chemistry and computer modeling to discover and d...

Portola Pharmaceuticals Inc PTLA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryPortola Pharmaceuticals Inc Portola Pharmaceuticals is a biopharmaceutical company which conducts research to develop therapeutics in the areas of thrombosis, other hematologic disorders and inflammation. The company's products portfolio include Betrixaban, an oral oncedaily Factor Xa inhibitor anticoagulant that inhibits the activity of Factor Xa; andexanet alfa, a recombinant protein desi...

BTG Plc BTG Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryBTG plc BTG develops, manufactures and sells medicines for acute care, cancer and vascular diseases. The company develops specialty drugs including antidotes for snake envenomation and toxicity related to medicines used for heart conditions and cancer; interventional vascular products for treating patients with severe blood clots and varicose veins; and interventional cancer products for tr...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks